QuestionQ22

VerifiedDomain III — Understanding how to govern AI development

You are the chief privacy officer for a medical research company that wants to collect and use sensitive data about cancer patients, including their names, addresses, race and ethnic origin, medical histories, insurance claims, pharmaceutical prescriptions, eating and drinking habits, and physical activity.

The company will use this sensitive data to build an AI algorithm that identifies common attributes to help predict whether seemingly healthy people are more likely to get cancer. However, the company cannot obtain consent from enough patients to collect the minimum amount of data needed to train its model sufficiently.

Which of the following solutions would most efficiently balance privacy concerns with the lack of available data during the testing phase?

Explanation

Synthetic data can supplement limited real patient data with algorithmically generated records that preserve useful distributions and correlations for testing and model development, while reducing reliance on additional identifiable health data. Differentially private synthetic data can provide a formal privacy guarantee when it is generated with an appropriate differentially private method.

Learn more

Community Discussion

No comments yet. Be the first to start the discussion!